Search
Search Results
##search.searchResults.foundPlural##
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1575PDF: 901HTML: 993figures: 199table 1: 199table2: 196table3: 199 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4874PDF: 1832HTML: 2730Untitled: 237 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4133Suppl. Files: 1184PDF: 1102Html: 238 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3356PDF: 1272HTML: 8145 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
871PDF: 490HTML: 1310 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1005PDF: 542HTML: 731 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3750PDF: 1260HTML: 3911Untitled: 239Untitled: 275 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3812PDF: 1617HTML: 586Figures . Eliassian: 235 -
IMMUNOLOGY OF TUBERCULOSIS
5499PDF: 2042HTML: 7345Untitled: 204 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
10760PDF: 6464HTML: 21826 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
978PDF: 577HTML: 2203Cover Letter: 202 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3405PDF: 1387HTML: 2702 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2179PDF: 1200HTML: 281 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1439PDF: 838HTML: 3126 -
-
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4504PDF: 1749HTML: 1109 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1236PDF: 612HTML: 6806 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1461PDF: 1348HTML: 111 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3388PDF: 1349HTML: 6208 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3095PDF: 1035HTML: 3112 -
-
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1371PDF: 1031HTML: 128 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
7162PDF: 4030HTML: 24901 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3287PDF: 1040HTML: 2144







